Edgewise Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
  • Edgewise Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.22M, a 30.2% increase year-over-year.
  • Edgewise Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $19.8M, a 34.2% increase year-over-year.
  • Edgewise Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.6M, a 60.7% increase from 2022.
  • Edgewise Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.9M, a 148% increase from 2021.
  • Edgewise Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.4M, a 1144% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $19.8M $5.22M +$1.21M +30.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $18.6M $4.87M +$1.03M +26.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $17.6M $5.15M +$1.42M +37.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $16.1M $4.56M +$1.39M +43.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $14.8M $4.01M +$1.97M +96.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $12.8M $3.84M +$1.86M +94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $10.9M $3.74M +$1.86M +99.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $9.06M $3.17M +$1.63M +105% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.44M $2.04M +$1.35M +197% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.09M $1.98M +$1.68M +568% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $4.4M $1.87M +$1.68M +886% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $2.72M $1.55M +$1.48M +2111% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.24M $687K +$638K +1302% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $605K $296K +$251K +558% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $354K $190K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $70K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $49K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $45K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.